Promising results for a first-in-class Usher syndrome IIA therapy

by DBGen Ocular Genomics

5 years ago
Retinitis pigmentosa, Usher syndrome, Therapy, biotechnology

The Dutch biotechnology company ProQR has just presented (March 2021) the first results of a clinical trial, named Stellar, with QR-421a, an antisense oligonucleotide designed to stop vision loss o...

Molecular Cancer Therapeutics. Discovered a combination therapy that could improve the survival of patients with aggressive brain tumours

by CNIO - Centro Nacional de Investigaciones Oncológicas

5 years ago
glioblastoma, brain tumours, dianhydrogalactitol, therapy

The researchers conducted an in-depth study of resistance to temozolomide, the first-line treatment for glioblastoma, to which many patients cease to respond over time

Seven European centers develop a web-based decision-making support tool for oncologist to improve treatment selection

by VHIO

6 years ago
virtual platform, oncologist, VHIO, therapy, molecular biomarkers

The molecular profiling of tumors has opened the door to more effective therapies adapted to the condition of each patient. However, this approach has posed new challenges to medical teams, who are re...

Smoking makes the follow-up of oxygen therapy worse in patients with COPD

by Fundació Clínic per a la Recerca Biomèdica

7 years ago
COPD, Obstructive Pulmonary Disease, smoking, pulmonary disease, therapy

It is important to follow the indications of the professionals and the treatment in order to improve the survival of the patients.

Aglaris Secures Major Funding to Drive Commercialisation of Ground- breaking Cell-based Therapy Manufacturing System

by CRB Health Tech

7 years ago
therapy, Aglaris, cell, gene

Aglaris Ltd, the innovator in cell therapy manufacturing, has been awarded three prestigious grants totalling over €2million to advance its breakthrough technologies towards commercialisation.

CAR T-cell therapy

by Asphalion

7 years ago
CAR, cell, cancer, therapy

While the success of autologous chimeric antigen receptors (CAR) T-cell medicines cannot be denied, with the recent approvals of Kymriah (tisagenlecleucel) and Yescarta (axicabtagene ciloleucel) pavin...

Designing advanced controllers for robotic rehabilitation devices

by Universidad del País Vasco

8 years ago
robots, rehabilitation, therapy, patients, reduced mobility

Robots allow rehabilitation therapies that are more precise and better adapted to the patients’ recovery status to be performed, according to a study by the UPV/EHU-University of the Basque Country